167 related articles for article (PubMed ID: 3042816)
21. Use of methotrexate in psoriasis.
Roenigk HH; Maibach HI; Weinstein GD
Arch Dermatol; 1972 Mar; 105(3):363-5. PubMed ID: 5012144
[No Abstract] [Full Text] [Related]
22. Reliability of the Roenigk classification of liver damage after methotrexate treatment for psoriasis: a clinicopathologic study of 160 liver biopsy specimens.
Berends MA; van Oijen MG; Snoek J; van de Kerkhof PC; Drenth JP; Han van Krieken J; de Jong EM
Arch Dermatol; 2007 Dec; 143(12):1515-9. PubMed ID: 18087000
[TBL] [Abstract][Full Text] [Related]
23. Hepatotoxicity of methotrexate in the treatment of psoriasis.
Roenigk HH; Bergfeld WF; St Jacques R; Owens FJ; Hawk WA
Arch Dermatol; 1971 Mar; 103(3):250-61. PubMed ID: 5548272
[No Abstract] [Full Text] [Related]
24. Methotrexate induced liver disease in psoriasis.
Millward-Sadler GH; Ryan TJ
Br J Dermatol; 1974 Jun; 90(6):661-7. PubMed ID: 4853200
[No Abstract] [Full Text] [Related]
25. Liver biopsy in psoriasis.
Berge G; Lundquist A; Rorsman H; Akerman M
Br J Dermatol; 1970 Mar; 82(3):250-3. PubMed ID: 5441759
[No Abstract] [Full Text] [Related]
26. Pulmonary and hepatic complications of methotrexate therapy of psoriasis.
Filip DJ; Logue GL; Harle TS; Farrar WH
JAMA; 1971 May; 216(5):881-2. PubMed ID: 5108291
[No Abstract] [Full Text] [Related]
27. Monitoring liver function during methotrexate therapy for psoriasis: are routine biopsies really necessary?
Thomas JA; Aithal GP
Am J Clin Dermatol; 2005; 6(6):357-63. PubMed ID: 16343024
[TBL] [Abstract][Full Text] [Related]
28. Changes in liver histology during methotrexate therapy of psoriasis correlated to the concentration of methotrexate and folate in erythrocytes.
Hendel J; Poulsen H; Nyfors B; Nyfors A
Acta Pharmacol Toxicol (Copenh); 1985 Apr; 56(4):321-6. PubMed ID: 4024960
[TBL] [Abstract][Full Text] [Related]
29. Liver biopsies upsilon liver scans in methotrexate-treated patients with psoriasis.
Geronemus RG; Auerbach R; Tobias H
Arch Dermatol; 1982 Sep; 118(9):649-51. PubMed ID: 7114866
[TBL] [Abstract][Full Text] [Related]
30. Systemic chemotherapy for psoriasis: a national survey.
Bergstresser PR; Schreiber SH; Weinstein GD
Arch Dermatol; 1976 Jul; 112(7):977-81. PubMed ID: 947151
[TBL] [Abstract][Full Text] [Related]
31. Methotrexate in psoriasis with and without leucovorin: effect of different dosage schedules on acute liver toxicity.
Zachariae H; Bjerring P
Acta Derm Venereol; 1982; 62(5):446-8. PubMed ID: 6183902
[TBL] [Abstract][Full Text] [Related]
32. Assessment of liver function using fasting bile salt concentrations in psoriasis prior to and during methotrexate therapy.
Lawrence CM; Strange RC; Summerly R; Scriven AJ; Elmahallawy M; Wood A; Fletcher PJ; Beckett GJ
Clin Chim Acta; 1983 Apr; 129(3):341-51. PubMed ID: 6851172
[TBL] [Abstract][Full Text] [Related]
33. Liver biopsies in patients on methotrexate for the treatment of psoriasis.
Callen JP; Hanno R
Int J Dermatol; 1980 May; 19(4):215. PubMed ID: 7399793
[No Abstract] [Full Text] [Related]
34. The use of antipyrine clearance to measure liver damage in psoriatic patients receiving methotrexate.
Paramsothy J; Strange R; Sharif H; Collins M; Shaw P; Lawrence CM
Br J Dermatol; 1988 Dec; 119(6):761-5. PubMed ID: 3203069
[TBL] [Abstract][Full Text] [Related]
35. Monitoring patients taking methotrexate for hepatotoxicity. Does the standard of care match published guidelines?
Petrazzuoli M; Rothe MJ; Grin-Jorgensen C; Ramsey WH; Grant-Kels JM
J Am Acad Dermatol; 1994 Dec; 31(6):969-77. PubMed ID: 7962779
[TBL] [Abstract][Full Text] [Related]
36. Revised guidelines on methotrexate use and liver biopsy.
Borislow DS; Davis I
Am J Gastroenterol; 1989 Jul; 84(7):841. PubMed ID: 2741901
[No Abstract] [Full Text] [Related]
37. Guidelines for routine liver biopsy during methotrexate treatment.
Cash JM; Wilke WS
Cleve Clin J Med; 1994; 61(4):317-8. PubMed ID: 7923752
[No Abstract] [Full Text] [Related]
38. [Laboratory and oligobiopsy examination of the liver in patients with psoriasis treated with methotrexate (preliminary report)].
Ruszczak Z; Prószyńska-Kuczyńska W; Babiński S; Biernat S; Kulig A
Przegl Dermatol; 1974; 61(6):803-7. PubMed ID: 4431967
[No Abstract] [Full Text] [Related]
39. [Incidence of liver diseases in psoriatic patients with special reference to methotrexate therapy].
Moldenhauer E; Dabels J; Diwok K; Leithäuser W; Nowotny P
Dermatol Monatsschr; 1973 Mar; 159(3):242-8. PubMed ID: 4704945
[No Abstract] [Full Text] [Related]
40. Letter: Methotrexate dosage schedule.
Rees RB
Arch Dermatol; 1974 Mar; 109(3):407. PubMed ID: 4814944
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
